In gliomas, (R)-2HG accumulation caused by oncogenic IDH mutations enhances DNA methylation and epigenetic remodeling, which stalls cell differentiation and thereby primes cells for malignancy (Figueroa et al., 2010; Ward et al., 2010; Lu et al., 2012). Here, IDH2 is linked to glioma.